Skip to main content
All lobbying filings

ELUSYS THERAPEUTICS INC FKA NIGHTHAWK BIOSCIENCES, INC.

Lobbying for ELUSYS THERAPEUTICS INC FKA NIGHTHAWK BIOSCIENCES, INC. · Biotechnology/pharmaceutical & biomanufacturing company

 Filing 2nd Quarter - Report
2nd Quarter (Apr 1 - June 30) 2025 · North Carolina · House · Senate · $220,000.00 expenses · posted Jul 21, 2025

Official filing document

 Bills named in this filing 1
  • HR 2707
    Protecting American Families and Servicemembers from Anthrax Act
 Lobbying activity 2
Defense

H.R. 2707, Protecting American Families and Servicemembers From Anthrax Act National Defense Authorization Act, 2026 Appropriations Legislation, 2026 Pandemic All Hazards and Preparedness Act Reauthorization

Health Issues

H.R. 2707, Protecting American Families and Servicemembers From Anthrax Act National Defense Authorization Act, 2026 Appropriations Legislation, 2026 Pandemic All Hazards and Preparedness Act Reauthorization

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem